Cell discovery · 2025
LZTR1 regulates epithelial MHC-I expression via NF-κB1 to modulate CD8+ T cells activation.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Jiang Rundong, Fang Zhiqin, Wang Yutong, Huang Bo, Liu Junkun, Tsoi Lam C, Bogle Rachael, Zhang Zongbo, Kuang Yehong, Li Xin, Dong Liang, Jin Liping, Gudjonsson Johann E, Yin Mingzhu, Chen Xiang
Аннотация
The role of CD8+ tissue-resident memory T (CD8+ TRM) in inflammation is well established. However, the mechanisms by which CD8+ TRM cells are activated in tissues have remained elusive. Here, we show that Leucine zipper-like transcription regulator 1 (LZTR1), a substrate adaptor for cullin3 (CUL3) ubiquitin ligase complex, regulates CD8+ TRM activation and proliferation in cutaneous and colonic epithelia through modulation of major histocompatibility complex class I (MHC-I) expression in an NF-κB1-dependent manner. Mechanistically, LZTR1 modulates MHC-I transcription by regulating co-translational biogenesis of NF-κB1 (p50) in a ubiquitination-independent but proteasome-dependent manner through direct binding with ribosome and proteasome. Loss of LZTR1 leads to suppression of CD8+ TRM activation and proliferation and decreased production of IL-17A with blunting of inflammatory responses in both cutaneous and gut epithelia in vivo. In summary, these data identify LZTR1 as a novel regulator of CD8+ TRM function and provide insights into the mechanisms that drive and maintain CD8+ T-cell responses in epithelial-associated autoimmune diseases.